OUTCOMES OF CHRONICALLY IMMUNOSUPPRESSED PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.
Christopher M Yao, MD, Samantha Tam, MD, MPH, Mona V Gajera, BS, Neha Desai, MPH, Xiaoning Luo, MD, PhD, Rachel Treistman, BS, Anshu Khanna, MPH, Randal S Weber, MD, Jeffrey N Myers, MD, PhD, Neil D Gross, MD
University of Texas MD Anderson Cancer Center
DEVELOPMENT OF GENE EXPRESSION SIGNATURE FOR RISK ASSESSMENT IN CUTANEOUS SQUAMOUS CELL CARCINOMA WITH A SUBANALYSIS IN THE HEAD AND NECK REGION
Jason G Newman, MD1, Ashley Wysong, MD2, Kyle R Covington, PhD3, Sarah J Kurley, PhD3, Kristen M Plasseraud, PhD3, Robert W Cook, PhD3, Chrysalyne D Schmults, MD, MSCE4, Sarah T Arron, MD, PhD5
1University of Pennsylvania Health System, 2University of Nebraska Medical Center, 3Castle Biosciences, Inc., 4Brigham and Women’s Hospital, 5University of California San Francisco
MANAGEMENT OF ACUTE RADIATION-INDUCED SKIN DERMATITIS WITH CAMWELL™ HERB-TO-SOOTHE CREAM IN HEAD AND NECK CANCER PATIENTS RECEIVING RADIOTHERAPY– A SINGLE INSTITUTION PILOT OBSERVATIONAL STUDY.
E Cecil, MSN, CRNP, Z Cheng, MD, MPH, P Han, PhD, B R Page, MD, A P Kiess, MD, PhD, H Quon, MD
The Johns Hopkins University
CLINICALLY NODE-NEGATIVE HEAD AND NECK MUCOSAL MELANOMA: AN ANALYSIS OF CURRENT TREATMENT GUIDELINES & OUTCOMES
Sina J Torabi, BA, Liliya Benchetrit, BA, Todd Spock, MD, Shayan Cheraghlou, BA, Benjamin L Judson, MD
Yale School of Medicine, Department of Surgery (Section of Otolaryngology)